Apyx Medical Corporation

APYX Healthcare Medical Devices

Apyx Medical Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.8 million, up 9.86% from fiscal 2024. In the quarter to June 2026, revenue grew 22.1%, EPS grew 22.2%, free cash flow fell 137.4% and total debt rose 2.74%, each against the same quarter a year earlier.

2.55 0.01 −0.39%
Market cap
$107.8M
P/E
0.0×
Fwd P/E
−16.0×
Dividend yield
—
F-score
4/9
Altman Z
1.10
Beneish M
−2.63
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
31.74 31.74 43.65 10.19 30.87 41.92 58.81 78.27 10.67 15.24
Receivables
16.78 15.48 14.02 18.25 21.16 17.33 9.65 5.08 4.86 4.73
Inventory
8.60 7.56 9.92 11.80 6.78 4.05 5.07 3.15 4.27 6.16
Total current assets
58.47 56.44 70.36 42.97 60.74 66.09 76.73 89.84 22.55 26.54
Property, Plant, Equpment (Net)
2.37 1.99 1.92 6.76 6.58 6.54 6.62 5.79 6.03 6.45
Goodwill and Intangible Assets (Total)
— — — — — — — — 0.25 1.91
Long-term assets (Other)
1.75 1.66 1.73 1.22 1.11 0.81 0.39 0.31 0.16 0.21
Total non-current assets
8.37 8.40 8.88 8.80 7.98 8.02 8.01 6.09 8.44 8.57
Total Assets
66.84 64.84 79.24 51.78 68.72 74.11 84.75 95.93 30.99 35.11
Notes Payable
— — — — — — 0.14 — 0.24 0.24
Accounts Payable
3.06 2.62 2.71 2.67 2.63 1.51 2.44 1.42 1.58 1.61
Accrued Expenses
8.21 7.75 9.66 8.93 10.29 7.28 9.40 7.19 3.03 3.43
Current Part of Capital Lease
0.02 0.02 0.02 0.04 0.17 0.24 0.23 — — —
Other current liabilities
— — — — — — — — 0.10 3.43
Total current liabilities
11.70 10.72 12.74 11.85 13.21 9.15 12.31 8.61 5.97 5.27
Long Term Debt (Total)
34.86 33.93 33.24 0.07 0.02 0.18 0.42 0.14 2.60 2.83
Non-current Revenue (Deferred)
— — — — — — — — — 0.01
Long Term Tax Liability (Deferred)
— — — — — — — — 0.37 0.56
Non-current Liabilities (Other)
1.40 1.38 1.44 1.59 1.49 0.79 0.52 0.00 0.02 0.20
Total non-current liabilities
40.31 39.79 39.58 2.13 1.51 1.10 1.18 0.14 2.98 3.62
Total liabilities
52.01 50.51 52.32 13.98 14.71 10.25 13.49 8.75 8.96 8.89
Additional Paid In Capital
103.62 92.08 81.11 73.28 66.22 61.07 56.71 52.92 50.50 49.63
Preferred Stock (Total)
— — — — — — — — — 0.00
Common Stock (Net)
0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03
Retained Earnings
(89.12) (77.91) (54.45) (35.73) (12.55) 2.62 14.52 34.22 (28.50) (23.43)
Common Equity (Total)
14.83 14.34 26.92 37.79 54.01 63.86 71.26 87.18 22.03 26.22
Shareholders Equity (Total)
14.83 14.34 26.92 37.79 54.01 63.86 71.26 87.18 22.03 26.22
Shareholders Equity and Liabilities (Total)
66.84 64.84 79.24 51.78 68.72 74.11 84.75 95.93 30.99 35.11
Shares (Common)
41.79 37.79 34.64 34.60 34.41 34.29 34.17 33.71 32.88 30.86
Shares (Preferred)
— — — — — — — — — 0.98
Shareholders Equity (Tangible)
14.83 14.34 26.92 37.79 54.01 63.86 71.26 87.18 21.78 24.31
Net Debt
3.12 2.19 (10.41) (10.12) (30.85) (41.73) (58.39) (78.13) (8.07) (12.40)
Total Debt
34.86 33.93 33.24 0.07 0.02 0.18 0.42 0.14 2.60 2.83

Fold the line items

In millions of $ except per-share values · columns are period end dates